Zdrowie i gospodarka · 11/03/2013

FDA Hosts Public Workshop on Developing New Treatments for Chronic Fatigue Syndrome and Myalgic Encephalomyelitis

The US Food and Drug Administration (FDA) is hosting a public workshop to discuss the development of new treatments for Chronic Fatigue Syndrome (CFS) and Myalgic Encephalomyelitis (ME), two conditions that affect millions of Americans.